Xenon does not trigger malignant hyperthermia in susceptible swine

Area of Science:

• Anesthesiology
• Pharmacology
• Veterinary Medicine

Background:

• Xenon, a noble gas, possesses anesthetic properties and is being explored for human use.
• Malignant hyperthermia (MH) is a severe, hypermetabolic complication of anesthesia.
• Investigating xenon's potential to trigger MH in susceptible individuals is crucial for patient safety.

Purpose of the Study:

• To determine if xenon anesthesia can induce malignant hyperthermia in MH-susceptible swine.
• To assess the safety of xenon as an anesthetic agent in a preclinical model of MH.

Main Methods:

• Nine MH-susceptible Pietrain swine were ventilated with 70% xenon/oxygen for 2 hours.
• Hemodynamic, metabolic, and plasma catecholamine levels were monitored throughout xenon exposure.
• Animals were subsequently challenged with halothane and succinylcholine to confirm MH susceptibility.

Main Results:

• Xenon administration did not elicit any signs or biochemical markers of malignant hyperthermia.
• All swine developed fulminant and fatal malignant hyperthermia within 20 minutes after halothane and succinylcholine administration.
• This confirms the animals' susceptibility to known MH triggers.

Conclusions:

• Xenon does not appear to trigger malignant hyperthermia in MH-susceptible swine.
• Xenon may represent a safer anesthetic alternative for patients with MH susceptibility.
• Further research is warranted to confirm xenon's safety profile in human MH-susceptible populations.